TETRACYCLINES INHIBIT TISSUE COLLAGENASE ACTIVITY - A NEW MECHANISM IN THE TREATMENT OF PERIODONTAL-DISEASE
TETRACYCLINES INHIBIT TISSUE COLLAGENASE ACTIVITY - A NEW MECHANISM IN THE TREATMENT OF PERIODONTAL-DISEASE
复制标题
DOI:
10.1111/j.1600-0765.1984.tb01334.x
复制
发表时间:
1984-01-01
影响因子:
3.5
通讯作者:
PERRY, H
中科院分区:
文献类型:
--
作者:
GOLUB, LM;RAMAMURTHY, N;PERRY, H
A nutnber of investigators have explored the use of systemically-administered or locallyapplied tetracyclines as adjuncts in the treatment of periodontal diseases both in humans and experimental animals (Ciancio, Mather & McMullen 1980. Williams et al. 1981, Kornman & Karl 1982, Slots & Rosling 1983. Lindhe, LiJjenberg & Adielason 1983. Hassan & Addy 1984. Goodson. Hogan & Dunham 1984). In all such studies, the etTicacy of this family of antibiotics was attributed solely to their suppression of subgingival periodontopathie microorganisms. In a recent investigation, minocychne (a semi-synthetic tetracycline) was found to possess a new, potentially ehemotherapeutically useful property: the ability to directly inhibit the activity of collagenolytic enzymes including, but not necessarily limited to, mammalian collagenase (Golub et al. 1983). The authors proposed that this property of tetracyclines could be clinically useful in treatitig diseases characterized by collagen breakdown.